X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
SUVEN LIFE Fact Sheet, SUVEN LIFE Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE Fact Sheet   (SVNP)

Here is the latest financial fact sheet of SUVEN LIFE. For more details, see the SUVEN LIFE quarterly results and SUVEN LIFE share price and chart. For a sector overview, read our pharmaceuticals sector report.

SUVEN LIFE Price History

Price Rs 199.8
Mkt Cap Rs m 23,343
Vol '000 61.4
P/E X 20.2
P/CF X 20.9
EPS (TTM) Rs 9.9
% ch % 0.6
No. of shares m 116.83
% ch week % -3.7
% ch 1-mth % 4.4
% ch 12-mth % 16.1
52 week H/L Rs 230.0/155.0
(As on Jan 22, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SUVEN LIFE Financials

No. of Mths
Year Ending
12
Mar-12
12
Mar-13
12
Mar-14
12
Mar-15
12
Mar-16
5-Yr Chart
Click to enlarge
SUVEN LIFE EQUITY SHARE DATA
High Rs263583323339 
Low Rs12142272144 
Sales per share (Unadj.) Rs17.522.143.740.939.2 
Earnings per share (Unadj.) Rs1.22.612.38.57.5 
Diluted earnings per shareRs1.22.612.39.38.1 
Cash flow per share (Unadj.) Rs1.73.313.19.58.8 
Dividends per share (Unadj.) Rs0.300.300.500.602.00 
Adj. dividends per shareRs0.300.300.500.652.18 
Dividend yield (eoy) %1.61.20.90.30.8 
Book value per share (Unadj.) Rs10.913.222.643.949.0 
Adj. book value per shareRs10.913.222.647.953.4 
Shares outstanding (eoy) m116.73116.82116.82127.28127.28 
Bonus/Rights/Conversions  -OI-IS- 
Price / Sales ratio x1.11.11.24.86.2 
Avg P/E ratio x15.19.24.323.132.4 
P/CF ratio (eoy) x10.77.44.020.827.5 
Price / Book Value ratio x1.71.82.34.54.9 
Dividend payout %24.411.44.17.026.8 
Avg Mkt Cap Rs m2,1712,8506,15625,10030,732 
No. of employees `000NANANA0.91.0 
Total wages/salary Rs m228254314365416 
Avg. sales/employee Rs ThNMNMNM5,912.15,236.1 
Avg. wages/employee Rs ThNMNMNM414.4436.5 
Avg. net profit/employee Rs ThNMNMNM1,234.4995.5 
SUVEN LIFE INCOME DATA
Net Sales Rs m2,0422,5795,1035,2094,995 
Other income Rs m19103086194 
Total revenues Rs m2,0612,5895,1335,2945,189 
Gross profit Rs m2325322,1911,5951,233 
Depreciation Rs m607988118167 
Interest Rs m991351054754 
Profit before tax Rs m913292,0271,5161,205 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m-5220586428255 
Profit after tax Rs m1443081,4421,088950 
Gross profit margin %11.320.642.930.624.7 
Effective tax rate %-57.16.128.928.221.2 
Net profit margin %7.012.028.220.919.0 
SUVEN LIFE BALANCE SHEET DATA
Current assets Rs m1,0491,3692,8064,7704,986 
Current liabilities Rs m1,0071,0741,5511,2741,042 
Net working cap to sales %2.111.424.667.179.0 
Current ratio x1.01.31.83.74.8 
Inventory Days Days8376565761 
Debtors Days Days4534472839 
Net fixed assets Rs m1,5611,6571,9212,7903,126 
Share capital Rs m117117117127127 
"Free" reserves Rs m7581,0262,1253,0743,717 
Net worth Rs m1,2751,5452,6455,5936,236 
Long term debt Rs m550642377615432 
Total assets Rs m2,8503,2764,8667,7318,079 
Interest coverage x1.93.420.333.223.2 
Debt to equity ratio x0.40.40.10.10.1 
Sales to assets ratio x0.70.81.00.70.6 
Return on assets %8.513.531.814.712.4 
Return on equity %11.320.054.519.415.2 
Return on capital %10.421.270.625.218.9 
Exports to sales %89.084.590.188.187.5 
Imports to sales %16.515.19.411.612.2 
Exports (fob) Rs m1,8182,1804,6004,5904,371 
Imports (cif) Rs m337389482602611 
Fx inflow Rs m1,8182,1804,7524,7794,666 
Fx outflow Rs m430515608855942 
Net fx Rs m1,3881,6654,1433,9243,724 
SUVEN LIFE CASH FLOW
From Operations Rs m 338 307 1,212 1,429 922 
From Investments Rs m -320 -147 -355 -1,105 -619 
From Financial Activity Rs m -18 26 -382 1,791 -698 
Net Cashflow Rs m -1 186 474 2,116 -396 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 63.4%
Foreign collaborators 0.0%
Indian inst/Mut Fund 0.0%
FIIs 0.0%
ADR/GDR 0.0%
Free float 36.5%
Shareholders 37,287
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF SDE Serene Chambers, Road No.5, Avenue 7, Banjara Hills, Hyderabad - 500 034
E-MAIL investorservices@suven.com WEB www.suven.com
TELEPHONE (040) 2354 3311 FAX (040) 2354 1152
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Karvy & Company
COMP SEC: K. Hanumantha Rao YEAR OF INC: 1989 BSE CODE: 530239 FV (Rs): 1 DIV YIELD (%): 1.1

More Pharmaceuticals Company Fact Sheets:   MERCK LTD  INDRAPRASTHA MEDICAL  DIVIS LABORATORIES  PFIZER  INDOCO REMEDIES  

Compare SUVEN LIFE With:   MERCK LTD  INDRAPRASTHA MEDICAL  DIVIS LABORATORIES  PFIZER  INDOCO REMEDIES  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Views on news

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE

SUVEN LIFE - MYLAN COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS